Primaa Cleo Breast and Cleo Skin

Organization
Primaa · France
Solution Type
Ready Product / Solution
Collaboration
Licensing, Business Collaboration (Joint Venture)

1. Technology overview

Primaa is a Paris-based medtech company founded in 2018 that develops AI software for automated cancer diagnosis on digital pathology slides. It addresses the shortage of pathologists and the time needed to review histology cases.

Cleo Breast detects and quantifies breast cancer biomarkers such as mitoses and invasive carcinoma, and Cleo Skin supports dermatopathology for skin cancers. The software uses deep learning image analysis and a smart worklist for triage and case prioritisation. Cleo Skin received CE marking under the IVDR in March 2026. Users in France include Institut Curie, AP-HP and Saint-Joseph Hospital.

2. Highlighted features & specifications

  • Breast cancer analysis: Cleo Breast detects mitoses and invasive carcinoma and quantifies biomarkers.
  • Micrometastasis detection: Cleo Breast received CE-IVDR marking for this use in September 2026.
  • Dermatopathology: Cleo Skin supports diagnosis of melanoma and skin carcinomas on slides.
  • Smart worklist: triage and prioritisation of cases.
  • Scanner and viewer integration: workflow integration with PathPresenter announced September 2026.
  • Scientific evidence: peer-reviewed studies published on the website.

3. Potential application

Large oncology hospitals in Vietnam could pilot breast cancer slide triage to shorten reporting time. Private pathology laboratories with slide scanners could add AI second reads. Teaching hospitals could use it for pathologist training and quality assurance.

4. Benefits

Supports pathologists with automated biomarker detection and quantification, which the company links to faster case review and higher diagnostic confidence. A smart worklist prioritises cases. CE-IVDR marking on Cleo Breast and Cleo Skin gives European labs a certified route to deploy AI in diagnostic workflows.

6. Other information

Founded in 2018, address 10 rue Bachaumont, Paris. Raised 7M EUR in October 2025 (Tech.eu). Cleo Skin CE-IVDR in March 2026 and Cleo Breast micrometastasis CE-IVDR in September 2026. Partners listed include AP-HP, Sectra, Unilabs, PathAI and Proscia.

Not ready to connect yet?

Save this solution and come back when you are ready to talk to the provider

Trusted by Our Partners

TechFest VietnamIOM – UN MigrationGIZ (Deutsche Gesellschaft für Internationale Zusammenarbeit)APED – Cục Phát triển doanh nghiệp tư nhân và kinh tế tập thểSIHUB – Startup and Innovation Hub of Ho Chi Minh CityHợp tác Đức (Deutsche Zusammenarbeit)SCE & Investment PromotionStartup Vietnam Foundation (SVF)National Startup Support Center (NSSC)01BoosterQuest VenturesBộ Tài chính (Ministry of Finance)ITPC – HCMC Investment and Trade Promotion CentreJICA – Japan International Cooperation AgencyNational Innovation Center (NIC)UK GovernmentBCG – Boston Consulting GroupHAWEEHeineken VietnamTalentnetMB BankVIREA – Liên chi hội Bất động sản Công nghiệp Việt NamJobTestGlobal Supply Chain Support Fund / Aavishkaar CapitalKDANPSE / JPS – Phúc Sang MinhG-AsiaPacificBlueScopeLPBankUlsan Center for Creative Economy & InnovationĐại học Bách khoa Hà Nội – Trường Điện - Điện tửVINK – Vietnam Innovation Network in KoreaTencent WeStart (Shenzhen)Ulsan CollegeK-StartupFaslinkShinhan Future's LabShinhan SecuritiesShinhan FinanceShinhan BankShinhan Life

Start with the right connection

We make innovation easy to access for every business everywhere. The next deal is you.

Contact Us